Valeritas, which markets a disposable device that delivers basal-bolus insulin therapy for Type 2 diabetes, filed on Thursday with the SEC to raise up to $90 million in an initial public offering.
Valeritas' IPO filing arrives just one week after insulin pump maker Asante Solutions (PUMP) postponed its proposed $49 million offering. Another insulin pump company, Tandem Diabetes Care (TNDM), has traded down about 45% from one year ago and -14% from three months ago.
Help employers find you! Check out all the jobs and post your resume.
Valeritas' IPO filing arrives just one week after insulin pump maker Asante Solutions (PUMP) postponed its proposed $49 million offering. Another insulin pump company, Tandem Diabetes Care (TNDM), has traded down about 45% from one year ago and -14% from three months ago.
Help employers find you! Check out all the jobs and post your resume.
